[Form 4] Lineage, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lineage, Inc. (LINE) – Form 4 insider filing: Director Nancy Joy Falotico reported the grant of 4,490 time-based restricted stock units (RSUs) on 18 Jun 2025. The RSUs convert to common shares on a 1-for-1 basis and vest in full on the earlier of (i) 18 Jun 2026 or (ii) the next annual shareholder meeting after 18 Jun 2025, contingent on continued board service. No cash was paid for the grant (reported price: $0). Following the award, Falotico’s total beneficial ownership increased to 14,027 common shares, held directly.

The filing reflects standard non-derivative director compensation and does not involve open-market purchases or sales. No derivative securities were created or exercised beyond the RSUs disclosed, and there were no dispositions. The transaction slightly increases insider alignment but is routine in nature and immaterial to Lineage’s capital structure.

Positive

• Insider alignment: Grant of 4,490 RSUs increases director ownership to 14,027 shares, modestly aligning board interests with shareholders.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine RSU grant; modestly increases director alignment, neutral share-count impact.

The Form 4 shows Director Falotico receiving 4,490 RSUs, bringing her holdings to 14,027 shares. Because the award is part of customary board compensation, is priced at $0, and represents a de-minimis fraction of Lineage’s outstanding shares, it carries no immediate valuation impact. The single-year vesting schedule encourages continued board service and modestly tightens insider alignment, but investors should view the event as administrative rather than market-moving.

Corporate Governance Expert

TL;DR: Standard equity retainer; supports alignment, governance neutral.

Granting equity to directors is best practice for aligning oversight incentives with shareholder interests. The 4,490-unit grant fits typical small-cap board retainer ranges and cliffs after one year or the next AGM, aligning tenure with vesting. No 10b5-1 plan was noted, so transparency remains intact. Overall governance quality unchanged; impact on ownership structure negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Falotico Nancy Joy

(Last) (First) (Middle)

C/O LINEAGE, INC.

46500 HUMBOLDT DRIVE

(Street)

NOVI MI 48377

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lineage, Inc. [ LINE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/18/2025		A		4,490	A	$0(1)	14,027	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock on a one-for-one basis and which vest in full on the earlier to occur of (i) June 18, 2026, and (ii) the date of the next annual meeting of the Company's stockholders following June 18, 2025, subject to continued service with the Issuer through such applicable date.

Remarks:

	/s/ Brian Golper, as Attorney-in-Fact for Nancy Joy Falotico	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Lineage (LINE) director Nancy Falotico acquire?

She received 4,490 restricted stock units, each convertible into one common share.

What is the vesting schedule for the new RSUs granted to LINE’s director?

The RSUs vest fully on the earlier of 18 Jun 2026 or the company’s next annual shareholder meeting after 18 Jun 2025.

What is Nancy Falotico’s total ownership in Lineage after the transaction?

Following the grant, she beneficially owns 14,027 LINE common shares.

Did the Form 4 disclose any insider sales of LINE shares?

No. The filing reports only an acquisition of RSUs; there were no dispositions.

Was the RSU grant part of a Rule 10b5-1 trading plan?

The form does not indicate that the transaction was executed under a Rule 10b5-1(c) plan.